Manager, IR and Corp Comm

This role is considered Hybrid.

Overview

Reporting to the Vice President, Investor Relations & Corporate Communications, this individual will play a pivotal role within the investor relations team by assisting in the planning, development, and implementation of investor programs, messaging and activities. The Manager will assist the IR team with summarizing reports prepared by the investment community, crafting and preparing communications materials used in IR events, analyzing and providing competitive intelligence to management, and coordinating investor engagement activities.

Key Responsibilities

• Support the implementation of strategies and programs for investor relations.
• Build and manage relationships with external constituents, including current and prospective shareholders and sell-side analysts.
• Collaborate with various corporate teams, including Clinical, Legal, Financial, Commercial, and Regulatory to support communication of Alnylam's business strategy, corporate vision, value proposition, and financial performance
• Help prepare IR related material including press releases, presentations, conference call scripts, and Q&A documents.
• Support investor facing events, including conference calls, in-person meetings, non-deal roadshows, and bus tours.
• Monitor and analyze market trends and competitor activities.
• Support the development of quarterly earnings materials and other investor communications.
• Provide periodic strategic insights and market intelligence to assist senior leadership in understanding relative performance and positioning
• Generate and publish IR summaries following earnings calls and major corporate milestones, as well as a biweekly IR report for senior management.
• Possess a deep understanding of handling of non-material public information and Regulation Fair Disclosure (RegFD) requirements.
• Track shareholder base, investor sentiment, peer performance, and capital market trends.

Qualifications

• Bachelor's degree or equivalent experience in Communications, Business, or related field.
• Proven experience in investor relations or related field; minimum 5 years of experience, preferably at a commercial-stage biotech company.
• Exceptional written and verbal communication and presentation skills.
• High proficiency in Microsoft Word, Excel, and PowerPoint.
• Strong analytical and financial analysis skills.
• Proficiency in managing time effectively and balancing multiple high priority projects at a time.
• Ability to effectively collaborate with cross-functional teams.
• Ability to work well and enjoy a fast-paced, unpredictable environment
• Strong appreciation for and understanding of discretion associated with regular handling of confidential information
• Strong commitment to compliance and ethical standards
• Ability to travel domestically and internationally (approx. 10%).

About Alnylam:Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture:Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.